BEWARE OF FAKE INSTITUTES WITH SIMILAR NAMES. blank    blank

Emergency use nod for Virafin

  Apr 27, 2021

Emergency use nod for Virafin

Q. What is the news?
A.  The Drug Controller General of India (DCGI) granted emergency use approval for pharma major Zydus Cadila’s antiviral drug ‘Virafin’, to treat moderate COVID-19 disease in adults.

Q. What is Virafin? 

Q. What are the findings of the clinical trials? 

Q. How the drug works?